NCT06689657

Brief Summary

Data from Santé Publique France show that since the onset of the health crisis (covid-19), there has been an increase in emergency room visits for mood disorders among children under 15 years of age, with a notable rise in the number of visits since early September 2020 compared to previous years. Recent literature considers Dialectical Behavior Therapy (DBT) as the only approach that has demonstrated (albeit weak to moderate) effects on the recurrence of self-harming behaviors. It is within this context, and based on these various findings, that the CARES program was developed (Understanding and Acting to Regulate Emotions and Suicidal Behaviors), aimed at adolescents who have engaged in suicidal behaviors or who have active suicidal ideation. The objective of this study is to compare the CARES program for adolescents alone to the CARES program for adolescents combined with a parent group using Non-Violent Resistance (NVR) on the occurrence of self-harming behaviors among adolescents who have engaged in suicidal acts and/or have active suicidal ideation, six months after the conclusion of the intervention. This is a prospective, randomized, open-label, single-center, controlled study with two parallel arms, with blinded assessment of the outcome measures.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
108

participants targeted

Target at P50-P75 for not_applicable

Timeline
27mo left

Started Jan 2025

Longer than P75 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress38%
Jan 2025Jul 2028

First Submitted

Initial submission to the registry

November 13, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 14, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

January 6, 2025

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 6, 2028

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 6, 2028

Last Updated

November 14, 2024

Status Verified

November 1, 2024

Enrollment Period

3 years

First QC Date

November 13, 2024

Last Update Submit

November 13, 2024

Conditions

Keywords

Suicide preventionCognitive-behavioral therapyDialectical Behavior TherapyNon pharmacological interventionAdolescent

Outcome Measures

Primary Outcomes (1)

  • Occurence of suicidal behavior

    Assessed with the Columbia Suicide Severity Rating Scale (C-SSRS)

    Variation between initial assessment and assessment 6 month post intervention

Secondary Outcomes (5)

  • Clinical improvement assessement (clinician)

    Variation between initial assessment and post-intervention and between initial assessment and 6 months post-intervention

  • Parenting stress

    Variation between initial assessment and post-intervention and between initial assessment and 6 months post-intervention

  • Parenting anxiety and depression

    Variation between initial assessment and post-intervention and between initial assessment and 6 months post-intervention

  • Adolescent depression

    Variation between initial assessment and post-intervention and between initial assessment and 6 months post-intervention

  • Suicidal ideation

    Variation between initial assessment and post-intervention and between initial assessment and 6 months post-intervention

Study Arms (2)

Adolescent group therapy (CARES) and parent group therapy (RNV)

OTHER

In the adolescent group, they will attend 8 group sessions during 1 month (2 sessions/week). There also will be a "boost" session 3 month after the last session. Parents will attend 4 group sessions during 1 month too (1 session/week). There will be 2 "boost" sessions : 1 month and 3 month after the last session Patients will be randomized in each group with blinded assessment

Other: Adolescent group therapy (CARES) and parent group therapy (RNV)

Adolescent groupe therapy (CARES) only

EXPERIMENTAL

In the adolescent group, they will attend 8 group sessions during 1 month (2 sessions/week). There will be a "boost" session 3 month after the last session Patients will be randomized in each group with blinded assessment

Behavioral: Cognitive behavioral group therapy for adolescents and non violent resistance group for parents

Interventions

In the adolescents group, this cognitive-behavioral group therapy will include emotion regulation skills, distress tolerance skills, cognitive strategies, work on values and problem-solving strategies Those sessions will include psychoeducation about adolescents, about suicidal ideation and suicidal behavior, coping with adolescent emotional distress, support on how to be a parent today (screen regulation...) and manage daily life

Adolescent groupe therapy (CARES) only

In the adolescent group, they will attend 8 group sessions during 1 month (2 sessions/week). There also will be a "boost" session 3 month after the last session. Parents will attend 4 group sessions during 1 month too (1 session/week). There will be 2 "boost" sessions : 1 month and 3 month after the last session Patients will be randomized in each group with blinded assessment

Adolescent group therapy (CARES) and parent group therapy (RNV)

Eligibility Criteria

Age12 Years - 16 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age from 12 to 16 years 11 months old
  • Active suicidal ideation and/or suicidal behavior during the last 6 months
  • The patient is referred by a healthcare professional

You may not qualify if:

  • Intellectual developmental disorder
  • Non-french speaking
  • Planned travel not allowing the complete following of the study
  • The patient, the parents or the legal guardian can not be correctly informed
  • The patient presents symptoms that prevent him from group interaction (behavior disorders, hallucinations, delirium)
  • The family already followed the same kind of program
  • The patient is already enrolled in a clinical trial or is taking a treatment off full market approval during 4 weeks before screening
  • The patient and the family are not affiliated to any healthcare insurance
  • No signed consent from parents or a legual guardian nor one of the parental authority holder
  • The patient did not consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Suicidal IdeationSuicide Prevention

Condition Hierarchy (Ancestors)

SuicideSelf-Injurious BehaviorBehavioral SymptomsBehavior

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Adolescent group therapy (CARES) and parent group therapy (RNV) vs Adolescent groupe therapy (CARES) only
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 13, 2024

First Posted

November 14, 2024

Study Start

January 6, 2025

Primary Completion (Estimated)

January 6, 2028

Study Completion (Estimated)

July 6, 2028

Last Updated

November 14, 2024

Record last verified: 2024-11